Treatment of Congenital Hearing Loss Secondary to Biallelic Mutations of the Otoferlin Gene (OTOF)
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Clinical Trial of EHT102 Injection in Pediatric Patients With Biallelic hOTOF Mutations (NCT07288580) | Shanghai Euhearing Therapeutics Co., Ltd | 2026-04-02 |
Track Treatment of Congenital Hearing Loss Secondary to Biallelic Mutations of the Otoferlin Gene (OTOF) automatically
Every clearance here is in the API, with alerts when new ones post.